PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.35%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
12.82%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
27.13%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
27.13%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
27.59%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
121.43%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
121.43%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.96%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.96%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-79.26%
Negative OCF growth while VALMT.HE is at 29.82%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-142.71%
Negative FCF growth while VALMT.HE is at 37.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-29.04%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 36.35%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.85%
5Y revenue/share CAGR under 50% of VALMT.HE's 31.96%. Michael Burry would suspect a significant competitive gap or product weakness.
1.36%
3Y revenue/share CAGR under 50% of VALMT.HE's 17.44%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-52.74%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 3068.17%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
172.35%
Below 50% of VALMT.HE's 4846.94%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-43.77%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 680.48%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
121.16%
Below 50% of VALMT.HE's 376.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
152.75%
Below 50% of VALMT.HE's 376.31%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
17.95%
Below 50% of VALMT.HE's 613.90%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
40.04%
10Y equity/share CAGR above 1.5x VALMT.HE's 22.41%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.47%
5Y equity/share CAGR 1.25-1.5x VALMT.HE's 33.33%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
28.79%
3Y equity/share CAGR similar to VALMT.HE's 30.16%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.14%
Our AR growth while VALMT.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.18%
Inventory growth well above VALMT.HE's 8.86%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.64%
Asset growth above 1.5x VALMT.HE's 1.59%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.97%
Positive BV/share change while VALMT.HE is negative. John Neff sees a clear edge over a competitor losing equity.
2.86%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-49.54%
We cut SG&A while VALMT.HE invests at 102.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.